文献速递消化道肿瘤与早癌消化内镜

中国食管癌内镜筛查(ESECC)的有效性:基于人群的随机对照试验设计与初步结果

Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial.
PubMed 文献 · Gut · 2018-01-06

ESECC试验是在中国河南滑县高发区开展的整群随机对照试验,将668个村庄按1:1随机分为内镜筛查组和无筛查对照组,2012年1月至2016年9月分别入组17151人和16797人;筛查组采用卢戈氏碘液染色内镜。初步结果显示,45-69岁人群食管及上消化道高级别病变的截断患病率分别为744.0/100000和902.0/100000,113例食管高级别病变患者中69.9%为早期。高龄、食管鳞癌家族史、低体重指数、进食快和常吃剩饭是该人群高级别食管病变的危险因素。

要点

  • ESECC是首个评估食管鳞癌内镜筛查有效性和成本效果的整群随机对照试验,共随机668个村庄。
  • 筛查组17151人、对照组16797人;45-69岁人群食管高级别病变截断患病率为744.0/100000。
  • 113例食管高级别病变患者中69.9%为早期;高龄、家族史、低体重指数、进食快和常吃剩饭为危险因素。

核心结论

  • ESECC试验达到了预设的入组和随机化要求。
  • 在该高危人群中,年龄、家族史、营养不良和不健康饮食习惯增加高级别食管病变风险。

研究设计与样本

  • ESECC试验是整群随机对照试验,在中国食管鳞癌高发区河南省滑县农村将668个村庄按1:1随机分为筛查组和对照组。
  • 筛查组采用卢戈氏碘液染色内镜筛查,对照组不进行筛查;将在未来10年随访中评估食管鳞癌特异性死亡、全因死亡、晚期食管鳞癌发病率和筛查成本效果。
  • 2012年1月至2016年9月,筛查组入组17151人,对照组入组16797人。

主要发现

  • 45-69岁人群食管高级别病变的截断患病率为744.0/100000,上消化道高级别病变的截断患病率为902.0/100000。
  • 113例食管高级别病变患者中,69.9%为早期。
  • 该人群中重度食管异型增生及更严重病变的危险因素包括较高年龄、食管鳞癌家族史、较低体重指数、进食快和频繁食用剩饭。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Description of the design and preliminary results of baseline recruitment and screening in the endoscopic screening for esophageal cancer in China (ESECC), the first randomised controlled trial (RCT) assessing efficacy and cost-effectiveness of endoscopic screening for esophageal squamous cell carcinoma (ESCC). DESIGN: ESECC trial is a cluster RCT, and 668 villages in rural Hua County, Henan Province, a high-incidence area of ESCC in China, were randomised into two arms at a ratio of 1:1. Screening arm participants were screened by Lugol chromoendoscopy; no screening was performed in the control arm. ESCC-specific and all-cause mortality, incidence of advanced ESCC and cost-effectiveness of screening will be evaluated in the next 10-year follow-up. Here, we report the performance of baseline recruitment and randomisation, prevalence of upper GI lesions and risk factors for ESCC. RESULTS: A total of 17 151 and 16 797 participants were enrolled in screening and control arms from January 2012 to September 2016. The truncated prevalence (aged 45-69 years) of oesophageal and overall upper GI high-grade lesions was 744.0/100 000 and 902.0/100 000. 69.9% of the 113 patients with high-grade oesophageal lesions were of early stage. Risk factors for severe oesophageal dysplasia and more severe lesions in this population included higher age, family history of ESCC, lower body mass index, eating rapidly and frequent ingestion of leftovers. CONCLUSION: This ESECC trial met the predesigned recruitment and randomisation requirements. Age, family history, undernutrition and unhealthy dietary habits increased the risk for high-grade oesophageal lesions in this high-risk population. TRAIL REGISTRATION NUMBER: NCT01688908; Pre-results.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. He Z, Liu Z, Liu M, et al. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial. Gut. 2018. PMID: 29306867. doi:10.1136/gutjnl-2017-315520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。